BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 5225921)

  • 1. Dilantin (diphenylhydantoin): its effects on the gingival tissue.
    Bergmann CL
    Dent Dig; 1967 Feb; 73(2):63-70. PubMed ID: 5225921
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of ultrastructural changes of the gingival hyperplasia induced by cyclosporine and dilantin.
    Helaiel EH; Lashin AN; Sobhi MA
    Egypt Dent J; 1992 Jan; 38(1):113-22. PubMed ID: 1343995
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 6. The gingival hyperplasia resulting from diphenylhydantoin in children and adults.
    Matsumoto K; Nakagawa K; Kaneko Z
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):369-71. PubMed ID: 1176242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenylhydantoin gingival hyperplasia: incidence and etiology.
    Zeitler DL; Zach GA
    J Hosp Dent Pract; 1980; 14(1):41-4. PubMed ID: 6964964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transport of immunoglobulins in the gingival epithelium. I. In diphenylhydantoin-induced hyperplasia].
    Perona M; Ibáñez P; Sagredo E; Pino A; Riera P; Tabernero M; Urcelay B; Ortiz G
    Av Odontoestomatol; 1985; 1(6):314-8, 321-3. PubMed ID: 3915870
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
    Silvestri E; Veraldi S; Piferi M; Sala F; Bencini L; Marini D
    Minerva Stomatol; 1988 Mar; 37(3):189-92. PubMed ID: 3166093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gingival hyperplasia induced by diphenylhydantoin. Clinical study of 106 cases].
    Peñarrocha Diago M; Bagan Sebastian JV; Antolin Rodriguez MM; Alfaro Giner A
    Rev Eur Odontoestomatol; 1989; 1(1):41-8. PubMed ID: 2700619
    [No Abstract]   [Full Text] [Related]  

  • 11. Epithelial hyperplasia in hydantoin induced hyperplastic and normal human gingiva.
    Larmas L; Paunio K
    Proc Finn Dent Soc; 1976 Oct; 72(5):177-9. PubMed ID: 981235
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diphenylhydantoin gingival hyperplasia: ultrastructural study].
    Aragona F; Franco V; Margiotta V; Cabibi D
    Stomatol Mediterr; 1988; 8(2):85-93. PubMed ID: 3256935
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histopathology of gingival manifestations of hydantoin therapy].
    Hanzély B
    Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinicopathological review. Diphenylhydantoin gingival hyperplasia: 2. Aetiology, pathogenesis, differential diagnosis and treatment.
    Angelopoulos AP
    Dent J; 1975 May; 41(5):275-7, 283. PubMed ID: 1055114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dilantin gingival hyperplasia--clinical, morphologic and histochemical observations].
    De Toledo BE; Lia RC; Utrilla LS; Sampaio LA
    Ars Curandi Odontol; 1978 Mar; 4(12):23-30. PubMed ID: 358954
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of diphenylhydantoin gingival hyperplasia among Egyptian children.
    Soliman NA; el-Ashiry GM; el-Gally KA; Attia MA
    Egypt Dent J; 1978 Jan; 24(1):11-22. PubMed ID: 292569
    [No Abstract]   [Full Text] [Related]  

  • 17. Gingival hyperplasia related to treatment with diphenylhydantoin (diphedan; DH).
    Rudas SL; Bárdos FV
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):180-4. PubMed ID: 4308214
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulins in periodontal tissues. III. Concentrations of immunoglobulins in dilantin-induced and idiopathic gingival hyperplastic tissues.
    Setterstrom JA; Gross A; D'Alessandro SM; Godat RF
    J Periodontol; 1980 Jan; 51(1):25-9. PubMed ID: 6928467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study.
    Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F
    J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the effect of the administration of diphenyl hydantoin and estrogens. II. Histopathological aspects of gingival changes in rats treated with diphenylhydantoin].
    Hernandez Vallejo G; Bascones A; Alonso A; Nieto-Camacho CM; Esteban M; Mosso MA; Lucas Tomas M
    Rev Esp Estomatol; 1984; 32(4):223-32. PubMed ID: 6599333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.